ISU Abxis Co., Ltd. (KOSDAQ:086890)
South Korea · Delayed Price · Currency is KRW 3,200.00
-150.00 (-4.48%)
At close: Nov 5, 2026
ISU Abxis Market Cap
ISU Abxis has a market cap or net worth of 130.48 billion as of November 5, 2026. It is the 25,117th most valuable company in the world and the 1,033rd biggest in South Korea. Its market cap has decreased by 36.25% in one year.
Market Cap
130.48B
Enterprise Value
129.15B
Revenue
51.04B
Global Rank
Country Rank
#1,033 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since February 3, 2009, ISU Abxis's market cap has increased from 55.97B to 130.48B, an increase of 133.14%. That is a compound annual growth rate of 4.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 130.48B | -36.58% |
| Dec 30, 2025 | 205.73B | 28.77% |
| Dec 30, 2024 | 159.77B | -23.70% |
| Dec 28, 2023 | 209.40B | 9.75% |
| Dec 29, 2022 | 190.80B | -34.58% |
| Dec 30, 2021 | 291.68B | 43.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IMBiologics | 182.79B |
| curacle co.,ltd. | 177.26B |
| Kangstem Biotech | 169.67B |
| NIBEC | 150.63B |
| Ensol Biosciences | 126.37B |
| Kanaph Therapeutics | 125.42B |
| Bio Solution | 124.76B |
| Y-Biologics | 120.01B |